https://seekingalpha.com/article/4679606-eido-indonesian-stocks-see-green-shoots-after-lost-decade?source=feed_tag_etf_portfolio_strategy
Mar 21, 2024 - iShares MSCI Indonesia ETF offers exposure to Indonesian companies, with heavy concentration in the financial sector. Explore more details here.
0
sa:698429259120742583
0
https://www.zacks.com/stock/news/2244071/wall-street-analysts-see-a-60-77-upside-in-lithium-americas-corp-lac-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2244071
Mar 21, 2024 - The mean of analysts' price targets for Lithium Americas Corp. (LAC) points to a 60.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
zc:-9026592566672233381
0
https://www.zacks.com/stock/news/2243476/wall-street-analysts-see-a-29-07-upside-in-turtle-beach-hear-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2243476
Mar 20, 2024 - The consensus price target hints at a 29.1% upside potential for Turtle Beach (HEAR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
zc:8378856157919191778
0
https://www.zacks.com/stock/news/2243349/wall-street-analysts-see-synopsys-snps-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2243349
Mar 20, 2024 - According to the average brokerage recommendation (ABR), one should invest in Synopsys (SNPS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
zc:4112818238914914971
0
https://www.zacks.com/stock/news/2243350/wall-street-analysts-see-toyota-motor-tm-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2243350
Mar 20, 2024 - The average brokerage recommendation (ABR) for Toyota Motor (TM) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
zc:5035706688253690308
0
https://www.denverpost.com/2024/03/20/xcel-energy-gas-rates-stay-flat-electric-bills-rise/
Mar 20, 2024 - Xcel Energy-Colorado expects its rates to stay relatively flat in the second quarter of 2024, with a slight rise in electric rates and a small drop in natural gas bills.
0
dp:392933349647927859
0
https://seekingalpha.com/news/4081379-crude-oil-hits-new-five-month-highs-but-citi-sees-possible-drop-to-55-by-late-2025?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
Mar 19, 2024 - Crude oil prices rise to new five-month highs as concerns about tightening supplies grow due to Ukrainian attacks on Russian refineries and global demand increases.
0
sa:6610116000828688521
0
https://www.zacks.com/stock/news/2242751/wall-street-analysts-see-ardmore-shipping-asc-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2242751
Mar 19, 2024 - The average brokerage recommendation (ABR) for Ardmore Shipping (ASC) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
zc:-6880712205994255192
0
https://www.startribune.com/twin-cities-realtor-agent-commission-buy-sell-house-market-real-estate-residential/600352156/
Mar 18, 2024 - There are more sellers, but there are also more buyers, so competition is stiff and houses are selling quickly.
0
sb:8549434371043916751
0
https://www.zacks.com/stock/news/2242201/wall-street-analysts-see-a-54-78-upside-in-arcutis-biotherapeutics-inc-arqt-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2242201
Mar 18, 2024 - The average of price targets set by Wall Street analysts indicates a potential upside of 54.8% in Arcutis Biotherapeutics, Inc. (ARQT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
zc:-3894997151328024434
0